MicroRNA-4443 regulates mast cell activation by T cell–derived microvesicles  Irit Shefler, PhD, Pazit Salamon, PhD, Francesca Levi-Schaffer, PharmD, Adam.

Slides:



Advertisements
Similar presentations
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Advertisements

Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,
Tsai-Der Chuang, Ph.D., Omid Khorram, M.D., Ph.D. 
Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity  Milena Milovanovic, MD, Guido Heine, MD, Werner Hallatschek,
The importance of being “pure” neutrophils
Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated.
Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,
Let-7 microRNA–mediated regulation of IL-13 and allergic airway inflammation  Manish Kumar, MSc, Tanveer Ahmad, MSc, Amit Sharma, PhD, Ulaganathan Mabalirajan,
Thymic stromal lymphopoietin downregulates filaggrin expression by signal transducer and activator of transcription 3 (STAT3) and extracellular signal-regulated.
Epigenetic regulation of established human type 1 versus type 2 cytokine responses  Ruey-Chyi Su, PhD, Allan B. Becker, MD, Anita L. Kozyrskyj, PhD, Kent.
Regulation of GM-CSF expression by the transcription factor c-Maf
Siglec-7 is an inhibitory receptor on human mast cells and basophils
Allergen-dependent solubilization of IL-13 receptor α2 reveals a novel mechanism to regulate allergy  Michael O. Daines, MD, Weiguo Chen, PhD, Yasuhiro.
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,
Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions  Mauro Giacomelli, PhD, Rajesh.
Is 9 more than 2 also in allergic airway inflammation?
Specificity protein 1 is pivotal in the skin’s antiviral response
Evidence of a role for B cell–activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps  Atsushi Kato, PhD,
Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice  László Hortobágyi, MS, Sonja Kierstein, PhD, Kateryna Krytska,
MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α  Dihan Zhu, MSc, Chaoyun Pan, MSc, Limin.
Dawn C. Newcomb, PhD, Madison G
The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells  Jane Eddleston, PhD, Jack Herschbach,
Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines  Maryam Salimi,
Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-α  John T. Schroeder, PhD,
The IL-17F signaling pathway is involved in the induction of IFN-γ–inducible protein 10 in bronchial epithelial cells  Mio Kawaguchi, MD, Fumio Kokubu,
Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps  Sarah Peterson, MD, Julie A. Poposki, MS, Deepti.
Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF- β1–stimulated primary human fibroblasts  Xiuxia Zhou, PhD, Haizhen.
Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma  Po-Jui Chang, MD, Pankaj K. Bhavsar, PhD,
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis  Bodi.
Posttranscriptional regulation of IL-13 in T cells: Role of the RNA-binding protein HuR  Vincenzo Casolaro, MD, PhD, Xi Fang, MD, Brian Tancowny, MS, Jinshui.
Bcl2-like protein 12 plays a critical role in development of airway allergy through inducing aberrant TH2 polarization  Zhi-Qiang Liu, MD, PhD, Ying Feng,
MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity  Jing Jing Li, MS, Hock L. Tay, PhD, Steven.
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
T-box 21 transcription factor is responsible for distorted TH2 differentiation in human peripheral CD4+ T cells  Osamu Kaminuma, DVM, PhD, Fujiko Kitamura,
IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells  Tadashi Sato, MD, PhD, Xiangde Liu, MD, Hesham Basma,
Nonreceptor tyrosine kinases ITK and BTK negatively regulate mast cell proinflammatory responses to lipopolysaccharide  Weishan Huang, PhD, J. Luis Morales,
Antiviral activity of human β-defensin 3 against vaccinia virus
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis  Deepti R. Nagarkar, PhD, Julie A. Poposki,
Downregulation of a disintegrin and metalloproteinase 33 by IFN-γ in human airway smooth muscle cells  Isao Ito, MD, PhD, Johanne D. Laporte, PhD, Pierre.
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)  Kornvalee Meesilpavikkai,
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease  Javier Milara, PhD, PharmD,
Connective tissue growth factor expression is regulated by histamine in lung fibroblasts: Potential role of histamine in airway remodeling  Steffen Kunzmann,
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
Mechanism of Siglec-8–mediated cell death in IL-5–activated eosinophils: Role for reactive oxygen species–enhanced MEK/ERK activation  Gen Kano, MD, PhD,
Lipoteichoic acid downregulates FcεRI expression on human mast cells through Toll-like receptor 2  Mino Yoshioka, MSc, Nobuyuki Fukuishi, PhD, Sayuri.
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts  Séverine Létuvé, PhD, Stéphane Lajoie-Kadoch, MSc, Séverine Audusseau,
Amplification of Toll-like receptor–mediated signaling through spleen tyrosine kinase in human B-cell activation  Shigeru Iwata, MD, PhD, Kunihiro Yamaoka,
Ian Ashmole, PhD, S. Mark Duffy, PhD, Mark L. Leyland, PhD, Valerie S
Activation of human mast cells through the platelet-activating factor receptor  Naoki Kajiwara, PhD, Tomomi Sasaki, BSc, Peter Bradding, DM, Glenn Cruse,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
MicroRNA-155 mediates downregulation of the high-affinity receptor for IgE through Toll-like receptor signaling  Nicole Leib, Dipl Biol, Nadine Herrmann,
Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE- independent secretion  Anja P. Bieneman, BS, Kristin L. Chichester,
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma  Elisabetta Pace, MD, Rosalia Gagliardo,
The coreceptor programmed death 1 inhibits T-cell adhesion by regulating Rap1  Inbar Azoulay-Alfaguter, PhD, Marianne Strazza, PhD, Ariel Pedoeem, BS,
IgE induces transcriptional regulation of thymic stromal lymphopoietin in human airway smooth muscle cells  Naresh Singh Redhu, MSc, Ali Saleh, PhD, Hai-Chon.
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Regulation of IL-13 receptor α1 expression and signaling on human tonsillar B- lymphocyte subsets  Oumnia Hajoui, PhD, Huaien Zheng, MD, PhD, Julie Guay,
Heterozygous N-terminal deletion of IκBα results in functional nuclear factor κB haploinsufficiency, ectodermal dysplasia, and immune deficiency  Douglas.
Autocrine-regulated airway smooth muscle cell migration is dependent on IL-17–induced growth-related oncogenes  Laila A. Al-Alwan, PhD, Ying Chang, PhD,
Julie Negri, BA, S. Brandon Early, BA, John W
Lower levels of hsa-mir-15a, which decreases VEGFA, in the CD4+ T cells of pediatric patients with asthma  Taiji Nakano, MD, Yuzaburo Inoue, MD, PhD,
Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma 
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Thymic stromal lymphopoietin links keratinocytes and dendritic cell–derived IL-23 in patients with psoriasis  Elisabetta Volpe, PhD, Lucia Pattarini,
IL-2–inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-γ in naive CD4+ T cells  Arun K. Kannan, MS, Nisebita.
Presentation transcript:

MicroRNA-4443 regulates mast cell activation by T cell–derived microvesicles  Irit Shefler, PhD, Pazit Salamon, PhD, Francesca Levi-Schaffer, PharmD, Adam Mor, MD, PhD, Alon Y. Hershko, MD, PhD, Yoseph A. Mekori, MD  Journal of Allergy and Clinical Immunology  Volume 141, Issue 6, Pages 2132-2141.e4 (June 2018) DOI: 10.1016/j.jaci.2017.06.045 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 mvT*s downregulate PTPRJ expression in MCs. A-D, LAD2 cells (Fig 1, A-C) or CBMCs (Fig 1, D) were incubated with mvTs or mvT*s (Fig 1, A and C) or activated by FcεRI cross-linking (Fig 1, B). PTPRJ mRNA levels were analyzed by using qRT-PCR and normalized to the levels of GUSB. Data are relative to untreated cells. E and F, PTPRJ protein levels were assessed by using Western blot analysis (Fig 1, E) and quantitated by using densitometric analysis (Fig 1, F). Results are shown from 3 independent experiments (means ± SEMs). *P < .05 and **P < .01. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Expression of miR-4443 in MCs stimulated by mvT*s. A, NanoString technology of RNA isolated from LAD2 cells activated by mvTs or mvT*s for 24 hours. B-D, LAD2 cells (Fig 2, B and C) or CBMCs (Fig 2, D) were incubated as indicated, and miR-4443 levels were measured by using qRT-PCR and normalized to RNU44 levels. Data are relative to untreated cells. E, Resting or phorbol 12-myristate 13-acetate (PMA)–activated Jurkat T cells or their microvesicles were analyzed for their miR-4443 content by using qRT-PCR. F, LAD2 cells were incubated with mvT*s in the presence of 50 μg/mL α-amanitin, and the selected miRs were evaluated by using qRT-PCR. Results are shown from 3 independent experiments (means ± SEMs). *P < .05 and **P < .01. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 miR-4443 regulates PTPRJ gene expression. Luciferase assay of LAD2 cells cotransfected with PTPRJ–3′-UTR reporter plasmid (LightSwitch) or empty vector and mimic miR-4443 or mimic. NC, Negative control. Results are representative of 3 different experiments. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 miR-4443 mimic or inhibitor regulates PTPRJ expression. A-C, LAD2 cells were transfected with 30 nmol/L miR-4443 mimic, its negative control (NC; Fig 4, A and B), or 30 nmol/L miR-4443 inhibitor or NC inhibitor (Fig 4, C) for 24 hours. Then the transfected cells were activated with mvTs or mvT*s for 24 hours (Fig 4, B and C). PTPRJ mRNA levels were measured by using qRT-PCR and normalized to levels of GUSB. Data are compared with mimic/inhibitor-NC–transfected cells. D, The PTPRJ protein level was measured by using Western blot analysis and was normalized to α-tubulin. This is a representative experiment of 3 different experiments. E, Densitometry presented as a percentage of mimic NC response. *P < .05 and **P < .01. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 miR-4443 regulates ERK phosphorylation in mvT*-activated MCs. LAD2 cells were transfected with 30 nmol/L miR-4443 mimic, mimic negative control (NC), miR-4443 inhibitor, or NC inhibitor for 24 hours. Thereafter, cells were stimulated with mvT*s for 24 hours. A, Levels of phosphorylated ERK (pERK) and α-tubulin were analyzed by using Western blotting. B, Densitometry from 1 representative experiment of relative bands of phospho-ERK presented as a percentage of mimic or inhibitor negative control (NC) response. C, LAD2 cells were transfected with 5 μg of PTPRJ expression plasmid or with the empty vector phosphorylated enhanced green fluorescent protein as a control for 48 hours, followed by activation with mvT*s for 24 hours. Levels of phosphorylated ERK, PTPRJ, and α-tubulin were analyzed by means of Western blotting. This is a representative experiment of 2 different experiments. D, Densitometry presented as a percentage of LAD2 cells with mvT*s. Results are shown from 2 independent experiments (means ± SEMs). *P < .05 and **P < .01. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 miR-4443 regulates IL-8 release in mvT*-activated MCs. LAD2 cells were transfected with 30 nmol/L miR-4443 mimic, mimic negative control (NC) (A), miR-4443 inhibitor, or NC inhibitor (B) for 24 hours. Thereafter, cells were stimulated with mvT*s for 24 hours. IL-8 release was assayed by means of ELISA. Results are shown from 3 independent experiments (means ± SEMs). *P < .05 and **P < .01. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 7 Proposed model of the effect of miR-4443 on mvT*-activated MCs. Activated T cells release microvesicles carrying miRNAs. These microvesicles are internalized into MCs, resulting in increased miR-4443 levels. High levels of miR-4443 downregulate PTPRJ gene expression, leading to increased ERK phosphorylation and augmented cytokine release. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 miR expression in MCs treated by mvT*s. RNA isolated from LAD2 cells activated by mvTs or mvT*s was analyzed for miR expression by using NanoString technology (A) or by using qRT-PCR and normalized to RNU44 levels (B). Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Time course of miR-4443 and PTPRJ expression in MCs treated by mvT*s. LAD2 cells were activated with 50 μg/mL mvT*s at different time points, and expression of miR-4443 and PTPRJ was measured by using qRT-PCR and normalized to the levels of RNU44 or GUSB, respectively. Data are relative to untreated cells. Results are shown from 3 independent experiments (means ± SEMs). Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 Expression of miR-4443 in MCs treated with anti-CD3/CD28–activated human peripheral blood T lymphocytes (mvTCD3/CD28). LAD2 cells were activated by microvesicles derived from resting cells or mvTCD3/CD28. miR-4443 levels were measured by using RT-PCR and normalized to RNU44 levels. Data are relative untreated cells. Results are shown from 3 independent experiments (means ± SEMs). **P < .01. Journal of Allergy and Clinical Immunology 2018 141, 2132-2141.e4DOI: (10.1016/j.jaci.2017.06.045) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions